ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the ARS Pharmaceuticals Third Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode.
Ars Pharmaceuticals Inc. (SPRY)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 10,860,977 | $114,583,307 | 1.52% | |
| 2. | Deerfield Management James E. Flynn | 10,514,657 | $110,929,631 | -6% | 2.1% |
| 3. | OrbiMed Advisors Samuel Isaly | 8,288,510 | $87,443,781 | 1.79% | |
| 4. | Alyeska Investment Group Anand Parekh | 1,253,724 | $13,226,788 | +903% | 0.04% |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,119,283 | $11,808,436 | +14% | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.79 | 505,954 | 9,958,073 | 2024-03-27 | Filing | ||
| $9.55 | 457,745 | 9,452,119 | 2024-03-26 | Filing | ||
| $9.06 | 437,600 | 8,994,374 | 2024-03-25 | Filing | ||
| $3.78 | 46,258 | Officer | 89,227 | 2023-09-29 | Filing | |
| $3.62 | 40,000 | Officer | 42,969 | 2023-09-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.31 | 50,000 | 210,346 | 2025-02-03 | Filing | ||
| $11.10 | 50,000 | 210,346 | 2025-01-06 | Filing | ||
| $11.67 | 50,000 | 1,098,499 | 2024-12-17 | Filing | ||
| $11.67 | 50,000 | 1,297,447 | 2024-12-17 | Filing | ||
| $11.67 | 50,000 | 1,098,499 | 2024-12-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,574,491 | $48,260,882 | 0% | |
| 2. | 4,012,903 | $42,336,127 | 10.32% | |
| 3. | 3,880,734 | $40,941,744 | 0.01% | |
| 4. | 3,464,952 | $36,555,244 | 0% | |
| 5. | 2,749,901 | $29,011,456 | 0% |
News See All
ARS Pharmaceuticals (SPRY): A Bull Case Theory
We came across a bullish thesis on ARS Pharmaceuticals (SPRY) on Value Degen’s Substack by Unemployed Value Degen. In this article we will summarize the bulls’ thesis on SPRY.
Where Should You Invest $1000 Right Now?
At least two different insiders have purchased a noteworthy amount of shares of all five of these stocks in the past three months.
Hedge Fund and Insider Trading News: George Soros, Ray Dalio, Millennium Management, Clough Capital, ARS Pharmaceuticals Inc (SPRY), Workday, Inc. (WDAY), and More
Millennium Management is shorting the stock of America Movil SAB, the telecommunications giant controlled by Mexican billionaire Carlos Slim.
5 Best Biotech Stocks to Buy Under $10
Ovid Therapeutics Inc. (NASDAQ:OVID) is an emerging biotech company that designs therapies for epilepsies, seizure-related disorders, and neurological disorders.
Billionaire Hedge Funds
